drugset / Trial / NCT00820300

A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma

NCT00820300

Phase 2 Completed 113 enrolled Mati Therapeutics Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if the Punctal Plug Delivery System is safe and effective in controlling intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Timeline

Start
2009-01
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule